Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasimelteon versus placebo for delayed sleep-wake phase disorder
2024-516962-13-00Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in delayed sleep-wake phase disorder (DSPD) comparing Hetlioz 20 mg with Placebo (2 arms). Started Sep 2022; status: completed.
02
Drugs
tasimelteon
03
Conditions
delayed sleep-wake phase disorder (DSPD)
Beyond the preview
Go deeper on 2024-516962-13-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516962-13-00.